Ricinus communis agglutinin I functionalisation of poly(methyl methacrylate) (PMMA) as a substrate for microfluidic device | |
Zhu DR ; Liu X ; Wang ZX | |
刊名 | science china-chemistry |
2012 | |
卷号 | 55期号:4页码:537-542 |
关键词 | CELL-CULTURE BINDING GLYCOSYLATION IMMUNOASSAYS INHIBITORS |
ISSN号 | 1674-7291 |
通讯作者 | wang zx |
中文摘要 | we report a functionalisation strategy which is able to generate ricinus communis agglutinin i (rca 120) modified pmma microfluidic device for binding and culturing living cells. the functionalisation is achieved by standard amine-aldehyde (schiff base) reaction through the cross-linker, glutaraldehyde. to prove the ability of the rca 120 modified pmma surface, the pc 12 cell line (rat pheochromocytoma cells) has been captured and cultured by the microfluidic device. in the presence of tunicamycin, the dose/time-dependence on decreasing of binding affinity of rca 120 modified device with pc 12 cell is also observed. the experimental results demonstrate that the lectin-functionalized microfluidic device can be employed as efficient cell culturing platform, and has a great promise of being used as a powerful tool for monitoring the interaction of drug with living cell. |
收录类别 | SCI收录期刊论文 |
语种 | 英语 |
WOS记录号 | WOS:000303184300011 |
公开日期 | 2013-10-09 |
内容类型 | 期刊论文 |
源URL | [http://ir.ciac.jl.cn/handle/322003/48839] |
专题 | 长春应用化学研究所_长春应用化学研究所知识产出_期刊论文 |
推荐引用方式 GB/T 7714 | Zhu DR,Liu X,Wang ZX. Ricinus communis agglutinin I functionalisation of poly(methyl methacrylate) (PMMA) as a substrate for microfluidic device[J]. science china-chemistry,2012,55(4):537-542. |
APA | Zhu DR,Liu X,&Wang ZX.(2012).Ricinus communis agglutinin I functionalisation of poly(methyl methacrylate) (PMMA) as a substrate for microfluidic device.science china-chemistry,55(4),537-542. |
MLA | Zhu DR,et al."Ricinus communis agglutinin I functionalisation of poly(methyl methacrylate) (PMMA) as a substrate for microfluidic device".science china-chemistry 55.4(2012):537-542. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论